Skip to content

Home
Products
About Us
OEM Franchise
News
FAQ

Home
Products
About Us
OEM Franchise
News
FAQ

Track Your Order

Search

Recent Posts

GLP – 1 Generic Drugs: Transforming the Pharmaceutical Landscape
Vetion Tirzepatide Injection Achieves WHO Prequalification Milestone, Accelerating Global Access to Affordable GLP-1 Therapy
Correct Usage and Precautions for Semaglutide Injection
Vetion Semaglutide Oral Tablets Obtain Thai FDA Marketing Authorization
Vetion’s New Factory Officially Put into Production, Annual Capacity Increased to 50 Million Units

Recent Comments

No comments to show.

Archives

September 2025
August 2025
July 2025
September 2023
August 2023

Categories

Company News
Industry Information
Industry News
News
Other channels
Product
Product Updates

World's leading GLP-1 generic supplier, providing cost-effective metabolic therapy drug solutions

Your Email Address *

By subscribing you agree to with our Privacy Policy andprovide consent to receive updates from our company

LEGAL

Track Your Order
Delivery & Returns
FAQ
Privacy Policy

Product Center

Semaglutide Oral Tablets
Semaglutide Injection
Tirzepatide Injection
OEM/ODM Services

COMPANY

About Us
News &Updates
FAQ

Contact Us

RM 509, 5/E THE CLOUD 111 TUNG CHAU ST TAI KOK TSUI HONG KONG
852-53782599
anda@vetinopharma.com
7x24 hours service

Copyright © 2026 | Powered by vetinopharma

Select your currency

USD United States (US) dollar

CNY Chinese yuan